Literature DB >> 8944684

Leptin is related to body fat content in male distance runners.

M S Hickey1, R V Considine, R G Israel, T L Mahar, M R McCammon, G L Tyndall, J A Houmard, J F Caro.   

Abstract

Leptin, the product of the ob gene, has been reported to be related to body fat in humans (Considine et al. N. Engl. J. Med. 334: 292, 1996). However, little is known about the physiology of this putative satiety signal in humans. The purpose of the present study was to determine whether leptin is related to body fat content in relatively lean endurance-trained adults. In addition, the effect of acute exercise on circulating leptin concentration was studied. Thirteen male runners, whose mean age, height, weight, %fat, and maximal oxygen consumption (VO2max) were 32.2 +/- 2.5 yr, 176.2 +/- 1.6 cm, 71.9 +/- 6.9 kg, 9.7 +/- 0.9%, and 62.9 +/- 2.2 ml.kg-1.min-1, respectively, were studied. Blood samples were obtained after an overnight fast and again immediately after the completion of a 20-mile run at 70% VO2max under controlled environmental conditions. Serum leptin was closely related to fat mass (r = 0.92) in the runners. Acute exercise had no detectable effect on serum leptin levels (PRE = 2.19 +/- 0.32 ng/ml, POST = 2.14 +/- 0.36 ng/ml). These data indicate that, even at a biological extreme of body fat, circulating leptin concentration is closely related to fat content. Furthermore, the data suggest that, in trained individuals with low leptin concentrations, acute exhaustive exercise has no immediate effect on circulating leptin concentration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8944684     DOI: 10.1152/ajpendo.1996.271.5.E938

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  19 in total

Review 1.  Biochemical aspects of overtraining in endurance sports: a review.

Authors:  Cyril Petibois; Georges Cazorla; Jacques-Rémi Poortmans; Gérard Déléris
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 2.  Plasma leptin and exercise: recent findings.

Authors:  Matthew W Hulver; Joseph A Houmard
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  Rapid decrease of leptin in middle-aged sedentary individuals after 20 minutes of vigorous exercise with early recovery after the termination of the test.

Authors:  I N Legakis; T Mantzouridis; A Saramantis; E Lakka-Papadodima
Journal:  J Endocrinol Invest       Date:  2004-02       Impact factor: 4.256

4.  Leptin levels do not change following acute exercise in healthy adults and in obese children.

Authors:  A Sartorio; F Agosti; A De Col; P G Marinone; N A Maffiuletti
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

Review 5.  Monitoring of performance and training in rowing.

Authors:  Jarek Mäestu; Jaak Jürimäe; Toivo Jürimäe
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

6.  Leptin responses to short term exercise in college level male rowers.

Authors:  J Jürimäe; T Jürimäe
Journal:  Br J Sports Med       Date:  2005-01       Impact factor: 13.800

7.  Plasma leptin and energy expenditure during prolonged, moderate intensity, treadmill exercise.

Authors:  M Zaccaria; A Ermolao; E Brugin; M Bergamin
Journal:  J Endocrinol Invest       Date:  2012-10-22       Impact factor: 4.256

8.  Daily hunger sensation and body compartments: II. Their relationships in obese patients.

Authors:  P Cugini; A Salandri; M Cilli; P Ceccotti; A Di Marzo; A Rodio; S Fontana; A M Pellegrino; G P De Francesco; S Coda; F De Vito; L Colosi; C M Petrangeli; C Giovannini
Journal:  Eat Weight Disord       Date:  1999-06       Impact factor: 4.652

Review 9.  Plasma leptin and exercise: recent findings.

Authors:  M S Hickey; D J Calsbeek
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

10.  Effect of resistance exercise (body building) training on serum leptin levels in young men. Implications for relationship between body mass index and serum leptin.

Authors:  A Gippini; A Mato; R Peino; M Lage; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  1999-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.